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Abstract
Parkinson’s disease (PD) is a neurodegenerative disease in which the etiology of 90 percent of the patients is unknown.
Pesticide exposure is a major risk factor for PD, and paraquat (PQ), pyridaben (PY) and maneb (MN) are amongst the most
widely used pesticides. We studied mRNA expression using transcriptome sequencing (RNA-Seq) in the ventral midbrain
(VMB) and striatum (STR) of PQ, PY and paraquat+maneb (MNPQ) treated mice, followed by pathway analysis. We found
concordance of signaling pathways between the three pesticide models in both the VMB and STR as well as concordance in
these two brain areas. The concordant signaling pathways with relevance to PD pathogenesis were e.g. axonal guidance
signaling, Wnt/b-catenin signaling, as well as pathways not previously linked to PD, e.g. basal cell carcinoma, human
embryonic stem cell pluripotency and role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis. Human
PD pathways previously identified by expression analysis, concordant with VMB pathways identified in our study were
axonal guidance signaling, Wnt/b-catenin signaling, IL-6 signaling, ephrin receptor signaling, TGF-b signaling, PPAR
signaling and G-protein coupled receptor signaling. Human PD pathways concordant with the STR pathways in our study
were Wnt/b-catenin signaling, axonal guidance signaling and G-protein coupled receptor signaling. Peroxisome proliferator
activated receptor delta (Ppard) and G-Protein Coupled Receptors (GPCRs) were common genes in VMB and STR identified
by network analysis. In conclusion, the pesticides PQ, PY and MNPQ elicit common signaling pathways in the VMB and STR
in mice, which are concordant with known signaling pathways identified in human PD, suggesting that these pathways
contribute to the pathogenesis of idiopathic PD. The analysis of these networks and pathways may therefore lead to
improved understanding of disease pathogenesis, and potential novel therapeutic targets.
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Introduction
Parkinson’s disease (PD) is the second most common neurode-
generative disease. It is characterized by tremor, rigidity, slowness
of voluntary movement and postural instability. The motor
symptoms of PD result from loss of dopaminergic (DA) neurons
in the substantia nigra (SN). Intracytoplasmic eosinophilic
inclusions composed of a-synuclein, are found in lewy bodies in
the remaining, intact nigral neurons [1]. Monogenic mutations
account for less than ten percent of all PD cases and the majority
of cases are sporadic [2,3]. As the etiology of the majority of
human PD cases is unknown, several neurotoxicant models of PD
have been developed to correctly model PD [4,5]. Evidence for an
environmental basis of PD comes from epidemiological studies and
experimental animals exposed to environmental toxins [6]
suggesting an important role of pesticides. Pesticides are defined
as any substance or mixture intended for preventing, destroying,
repelling or mitigating pests.
Many commonly used pesticides cause mitochondrial dysfunc-
tion and oxidative damage, similar to that observed in idiopathic
PD [7–9]. Paraquat (PQ) is the third most commonly used
herbicide in the world, and was identified as a neurotoxicant based
on structural similarities to MPP
+ (1-methyl-4-phenylpyridine), the
active metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP). PQ is a redox cycler, pyridaben (PY) inhibits mitochon-
drial complex I [8], and maneb (MN) inhibits mitochondrial
complex III [10]. Exposure to PQ or MN or their co-exposure
causes loss of DA neurons in animal models and MN exacerbates
the toxicity of PQ in mice [11]. Repeated PQ injections produce
selective loss of nigral DA neurons, and a-synuclein aggregation
within neurons of the SN pars compacta [12].
In rural environments, where workers were co-exposed to PQ
and MN several studies have clearly shown a marked increase in
Parkinson’s type neurodegeneration [13]. In the present experi-
ments, we examined the effects of pesticide exposure on gene
expression. We administered the pesticides by subcutaneous alzet
pumps and sacrificed mice at day 7. We believe the use of osmotic
pump is advantageous because it will deliver pesticide at a constant
rate as opposed to the episodic peaks in levels observed with intra-
peritoneal (i.p) injections.
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postmortem brain samples from human PD patients [14–17].
Consensus pathways were identified in a cross comparison of
whole genome expression profiles using standardized pathway
analysis [18] and compared to genome wide association studies
[19]. Prior in vivo studies examined gene expression profiling in PQ
and MN+PQ treated mice, but there are no reports on PY alone
[20,21].
Exposure to pesticides may elicit alterations in signaling
pathways in the VMB and STR, which may be useful in
identifying targets for therapeutic intervention. In the present
study, after showing that pesticide treatment induces consistent cell
death of DA neurons in the SN, we used RNA-Seq next
generation sequencing technology to comprehensively quantify
expression levels of all known genes and isoforms in treated versus
untreated animals. We then examined them by standardized
pathway analysis using Ingenuity Pathway Analysis (IPA). We
examined samples of VMB and STR which then allowed
assessment of the involvement of both non neuronal and neuronal
populations in pesticide models of PD. We observed that PQ, PY
and MNPQ elicit concordant signaling pathways in the VMB and
STR, which concur with pathways obtained from human PD gene
expression profiling, and genome wide association studies.
Results
Pesticide Induced Loss of TH+ Neurons and Increased a-
synuclein Aggregates
Tyrosine hydroxylase (TH) immunostaining showed a signifi-
cant loss of TH+ neurons in the SN of PQ, PY and MNPQ
exposed mouse models (Figure 1A). The percent loss of TH+
neurons in SN of PQ, PY and MNPQ mouse models were
significantly less than controls by 35%, 24% and 42% respectively
at p=0.05. The fold increase of a-synuclein aggregates in PQ
mouse model was 1.8 which was not significant, while in the PY
and MNPQ models the alpha-synuclein increased by 2.2 and 7.1
fold respectively, which were significant (p=0.05) (Figure 1B).
Therefore, the administration of pesticides PQ, PY and MNPQ
using subcutaneous alzet pump for one week was able to model
PD, by eliciting a significant loss of TH+ neurons in the SN along
with an increase in a-synuclein immunoreactivity.
PQ, PY and MNPQ Induce Differential Gene Expression in
VMB and STR
Since we had a moderate but not complete loss of TH+ neurons,
we examined whether we could detect early signaling events by
monitoring mRNA expression changes by transcriptome sequenc-
ing. Differential gene expression in the VMB and the STR in the
PQ, PY and MNPQ models was observed with RNA-Sequencing.
RNA-Seq gene expression raw data from VMB and STR from PQ,
PY, MNPQ and control samples have been deposited in NCBI’s
Gene Expression Omnibus (GEO) and are accessible through GEO
Series accession number GSE36232 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE36232). Average fold changes
across replicates were determined and compared to wild type
control mice for every gene and/or isoform in a reference sequence
(RefSeq) collection. The RNA-Seq gene expression fold changes
were validated for seven PD genes by Taqman assays (Table 1).
Gene expression fold changes in VMB and STR (Figure 2A and
Figure 2B respectively) were determined using the 2
2DDCt method
as compared to 18S ribosomal RNA as a housekeeping gene, and
normalized to controls. When the gene expression fold changes
were less than 0.3 different as determined by RNA-Seq or Taqman
assay and in the same direction we considered them concordant.
There was a seventy one percent concordance between gene
expression fold changes as determined by RNA-Seq and Taqman
assays.
To compare the common transcripts between pesticides we used
the web based tool venny (http://bioinfogp.cnb.csic.es/tools/
venny/index.html). We compared the 500 up- and down-
regulated transcripts in the PQ, PY and MNPQ models to link
the common genes in our study to the most significant pathways
previously identified in PD. The common up- and down-regulated
transcripts in the VMB are depicted in Figure 3A and Figure 3B
respectively, and their gene identifiers provided in Figure 3C and
Figure 3D respectively. The common up- and down-regulated
transcripts in STR are depicted in Figure 4A and Figure 4B
respectively, and their gene identifiers provided in Figure 4C and
Figure 4D respectively. We further describe some of the most
interesting genes in relationship to possible involvement in PD
pathways. The up-regulated VMB transcripts Slc8a1, Plce1 and
Cacna1e belong to calcium signaling pathways. These changes in
calcium signaling may be important in relationship to PD
pathogenesis [22]. PD patients taking calcium channel blockers
show a twenty seven percent reduction in risk of developing PD
compared to those not using these drugs [22]. Reducing Ca
2+
influx into SN DA neurons increases the resistance of these
neurons to toxins which are used to generate animal models of PD
[23].
Some of the other up-regulated transcripts in the VMB include
members of axon guidance signaling (Rock1, Adam22), zinc finger
proteins (Eif2c3 and novel KRAB box and zinc finger, C2H2 type
domain containing protein) and one of the candidate genes for late
onset Alzheimer’s Disease (Plce1) [24]. Nps (neuropeptide S)
stimulates dopaminergic neurotransmission [25], MBoat2 belong-
ing to MBOAT family of multispanning transmembrane enzymes,
catalyze the acylation of secreted signalling proteins of the
Hedgehog, Wnt and ghrelin families [26].
Some of the significant genes in our study (Table S1 and Table
S2) have been linked to PD. Nrtn (neurturin precursor) expression
was down-regulated in the VMB of PQ and MNPQ mouse
models. NRTN belongs to the glial cell line-derived family of
neurotrophic factors, which have been recognized to have the
potential to repair damaged and degenerating neurons and restore
their function. Interestingly, delivery of Nrtn using adeno
associated viral (AAV) vectors has been tested in human PD,
and nonclinical translational experiments to test the safety,
feasibility and effectiveness of targeting the SN with AAV2-Nrtn
to support clinical studies to enhance the trophic response in PD
DA neurons [27]. Phox2a (paired mesoderm homeobox protein
2A) expression was down-regulated in the VMB of PY mouse
model. Phox2a along with Lmx1b (LIM-homeodomain protein) are
part of a novel gene regulatory network that controls the
spatiotemporal generation of DA neurons during midbrain
development [28]. Another gene down-regulated in the VMB of
PY model is, urocortin precursor (Ucn), a group of peptides, closely
related to corticotrophin-releasing factor (CRF). Ucn has been
reported to arrest the progression of or even reverse nigral lesions
in the rat 6-hydroxydopamine (6-OHDA) and lipopolysaccharide
(LPS) models of PD [29]. Bcl2a1 (B-cell lymphoma 2-related
protein A1) is up-regulated in the VMB of PY model in our study.
Bcl2a1 is a highly regulated nuclear factor kB (NF-kB) target gene
that has important pro-survival functions [30]. Vitamin D induced
Camp gene up-regulated in VMB of PY model encodes cathelicidin
antimicrobial peptide, which initiates the innate immune responses
to bacterial infection, and can act as signaling molecule to regulate
immune system function [31].
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STR of MNPQ mouse model. This gene encodes a protein that
catalyzes the first step in the heme biosynthetic pathway. The
expression of Alas2 along with Fech and Blverb, the other heme
metabolism genes is tightly correlated with a-synuclein expression
in human PD [32]. This correlates with MNPQ mouse model
having the highest fold increase of a-synuclein in our study.
Human serum amyloid A (Saa), a high-density lipoprotein-
associated lipoprotein upregulated in VMB of MNPQ mouse
model is known to modulate inflammation and the metabolism
and transport of cholesterol [33]. Dysregulation of ion channels
are known to cause pathology in PD [34]. Ion channel genes
which ranked high in our gene list included ionotropic glutamate
receptor genes (Grin2a, Grin2b), ligand gated chloride channel gene
(Gabra6) and potassium voltage gated channel genes (Kcnh7). Grin2a
is also a PD disease modifier gene via an interaction with coffee
[35]. Ryr2 (Ryanodine receptor 2, cardiac) was up-regulated in the
STR of PQ model in our study. An up-regulation of Ryr2 receptors
with paraxanthine (PX; 1,7-dimethylxanthine), the primary
metabolite of coffee was found to be protective against MPP+ in
vitro [36]. The top ranking ten up-regulated and down-regulated
genes of PQ, PY and MNPQ datasets identified by IPA in the
VMB and STR are listed in Table S1 and Table S2 respectively.
In summary, we found several differentially expressed genes that
are related to PD or other neurological diseases, we therefore
decided to perform a systematic analysis to look for cell signaling
and metabolic pathways, and gene networks to identify potential
targets for therapeutic intervention.
Concordant Signaling Pathways in the VMB and STR of
PQ, PY and MNPQ Mouse Models
In order to find enriched signaling pathways in PQ, PY and
MNPQ mouse models from the VMB and STR, IPA was
employed. All differentially expressed genes with $1.5 or #1.5
fold changes were uploaded for analysis. The top ten canonical
pathways in the VMB of PQ, PY and MNPQ models of PD along
with associated molecules are listed in Table S3, Table S4 and
Table S5 respectively. We found pathways previously implicated
in human PD such as such as axonal guidance signaling [17,37],
pathways linked to other neurodegenerative diseases such as Wnt/
b catenin signaling [38], in addition to pathways not previously
associated with PD such as basal cell carcinoma, role of
osteoblasts, osteoclasts and chondrocytes in rheumatoid arthritis,
human embryonic stem cell pluripotency, role of macrophages,
fibroblasts and endothelial cells in rheumatoid arthritis. Alterations
in Wnt signaling are associated with neurodegenerative diseases
while overactivation of Wnt signaling is a common theme in
several types of human tumors [38]. The top ten canonical
pathways in the STR of PQ, PY and MNPQ models of PD are
listed in Table S6, Table S7 and Table S8 respectively.
Considering the top ten pathways in the three pesticide models,
there were six concordant pathways in the VMB (Figure 5A) and
three concordant pathways in the STR (Figure 5B). The three
Figure 1. Pesticide induced loss of TH+ neurons and increased a-synuclein immunoreactivity. A) Immunostaining of SN of PQ, PY, MNPQ
and wild type (WT) mice with tyrosine hydroxylase antibody. B) Percent loss of TH+ neurons and fold increase of a-synuclein immunoreactivity
compared to wild type control mice.
doi:10.1371/journal.pone.0036191.g001
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pathways were Wnt/b-catenin signaling, human embryonic stem
cell pluripotency and basal cell carcinoma signaling (Figure 5C).
Some of the significant canonical pathways in the VMB and
STR of PQ, PY and MNPQ mouse models were common with
pathways observed in human PD (Table 2 and Table 3) [18].
Therefore, axonal guidance signaling and wnt/b catenin signaling,
and their associated genes are not only common between
individual pesticide models, but also overlap with human PD.
Common Genes from Network Analysis in Pesticide
Models of PD
The genes from the most significant network of each individual
pesticide were used to generate global gene networks in the VMB
(Figure 6) and the STR (Figure 7). Red indicates up-regulated
genes, green indicates down-regulated genes and grey indicate no
change in gene expression. The higher the intensity of the color,
higher the gene expression fold-change. Network representation
allows investigation of functional associations of commonly
expressed genes following exposure to PQ, PY and MNPQ. The
key genes in the VMB network are Keap1 (kelch-like ECH-
associating protein 1), Ppard (peroxisome proliferator-activated
receptor delta), MAPKs (mitogen activated protein kinases) and
several GPCRs (G protein coupled receptors), are all down-
regulated. The key genes in the STR network are Atxn1 (ataxin 1)
which is up-regulated, while Ppard and several GPCRs are down-
regulated. Ppard and GPCRs are common in both VMB and STR,
indicating that they could be therapeutic targets.
The common GPCR’s in VMB and STR are Gpr101, Gpr135,
Gpr,150, Gpr153, Gpr162, Gpr25, Gpr27, Gpr3, Gpr62, metabotropic
glutamate receptors (Grm2 and Grm4), cholecystokinin B receptor
(Cckbr), chemokine C receptor 4 (Ccr4), histamine receptor (Hrh3
and Hrh6), Kiss1 receptor (Kiss1r) and prostaglandin E receptor 1
(Ptger1). The other common molecule in the VMB and STR is a-2
adrenergic receptor (Adra2c) which has been associated with PD
[39]. These findings therefore show that pesticides alter gene
expression in networks, some of which have been implicated in the
pathogenesis of PD.
Discussion
In our study, administration of pesticides produced the
neuropathological features of PD, in that they produced loss of
nigrostriatal DA neurons and increased a-synuclein immunoreac-
tivity, which is a protein found in lewy bodies, and is the most
characteristic feature of idiopathic PD. Our mouse models of PQ,
PY and MNPQ exposure produced 35%, 24% and 42% loss of
nigrostriatal neurons, allowing us to examine RNA changes in
circumstances in which the observed alterations are not merely a
reflection of cell loss and gliosis. Our results are the first to show
that PY exposure in mice can model PD, in that it produces a
significant loss of TH+ neurons in the SN and a-synuclein
aggregates. This is the first comprehensive evaluation using RNA-
Seq of the transcriptome of brains from PQ, PY and MNPQ
treated mice. Our PQ and MNPQ models are similar to previous
models in that we observed a loss of TH+ neurons and increased
a-synuclein aggregates. The fold increase of a-synuclein aggre-
gates in the PQ mouse model was 1.8 which was not significant in
our study. Paraquat induced upregulation of a-synuclein as
assessed by immunohistochemistry has also been reported in
previous PQ models of PD, although the stereological technique
for quantification of dopaminergic neurons was not performed by
any of the groups. We observed an exacerbation of toxicity with
the combination of PQ and MN as previously reported [40]. In
our experiments, we administered the pesticides using alzet
pumps, which have the advantage of producing a more even
exposure, which is more likely to mimic human exposure than the
pulsatile effects of i.p. injections.
The genes identified by network analysis in both the VMB and
STR are, peroxisome proliferator activated receptor delta (Ppard)
and G protein coupled receptors (GPCRs). While Keap1 and
MAPK’s are specific to VMB, Atxn1 is specific to STR. Evidence
for a role of GPCRs in PD comes from in vitro studies and animal
models supporting the use of agonists of Group III metabotropic
glutamate (mGlu) receptors belonging to the GPCR family, as
potentially important drug targets for providing beneficial
symptomatic effects [41]. Therefore, group III mGlu receptors
are promising targets for drug discovery in PD.
PPARd regulates the expression of peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (Pgc-1a). This is of
particular importance due to a recent meta-analysis of microarray
gene expression studies of PD postmortem brain tissue which
showed that PGC-1a expression is significantly reduced [42].
Furthermore, PARKIN deficiency results in increased levels of the
protein PARIS which binds to the PGC-1a promoter, and reduces
its expression, and producing loss of dopaminergic neurons [43].
PGC-1a regulates the antioxidant enzymes, Cu/Zn superoxide
dismutase (Sod1), and manganese superoxide dismutase (Sod2) and
glutathione peroxidase (Gpx1) [44] and also controls mitochondrial
biogenesis [45]. PPARd and PGC-1a cooperatively induce heme
oxygenase-1 (Ho-1) called Hmox1 in mice [46]. The nuclear
translocation of HO-1 also referred to as heat shock protein 32
Table 1. Taqman assays used for quantitative RT-PCR.
Taqman Assay ID Gene Symbol Description
Mm01208835_m1 PPARGC1A Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
(PGC-1a)
Mm01188700_m1 PARK1 Alpha-synuclein (SNCA)
Mm00450186_m1 PARK2 E3 ubiquitin-protein ligase (PARKIN)
Mm00550827_m1 PARK6 PTEN induced putative kinase 1 (PINK1)
Mm00498538_m1 PARK7 DJ-1
Mm00432893_m1 DRD4 D(4) dopamine receptor
Mm00452129_m1 SIRT3 NAD-dependent deacetylase sirtuin-3
Hs99999901_s1 RN18S 18S Ribosomal RNA
doi:10.1371/journal.pone.0036191.t001
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of its activity. This inactive nuclear form of HO-1 influences the
expression of cytoprotective genes [47]. Impairment of HO-1
production following oxidative stress accelerates the neurodegen-
eration in cellular models with mutant PINK1 [48]. Since, there is
evidence for a deficiency of PGC-1a in PD [42] and there is
evidence of mitochondrial dysfunction and increased oxidative
damage in PD [9], a deficiency of PPARd may play an important
role in PD pathogenesis.
Oxidative stress has been associated with the etiology of both
sporadic and monogenic forms of PD. Therefore, the down-
regulation of Keap1 in VMB in our study is significant because the
Nrf2-Keap1 pathway orchestrates protection of cells against
oxidative stress by up-regulating expression of nuclear cytopro-
tective genes. This classic adaptation has been designated the
environmental stress response (ESR) [49]. KEAP1 acts as a stress
sensor, whereas NRF2 serves as the effector of the ESR. Besides,
KEAP1 also senses the intracellular concentrations of NO (nitric
oxide), Zn
2+, and alkenals, which collectively serve as second
messengers that may signify danger and/or damage [49]. When
the KEAP1 sensor is down-regulated, the effector NRF2 may be
ineffective in inducing cytoprotective genes.
Dj-1, is one of the genes responsible for early onset autosomal
recessive PD. DJ-1, the protein product of Dj-1, stabilizes NRF2 by
Figure 2. Validation of RNA-Seq gene expression fold changes by Taqman real time PCR. A) Gene expression fold changes in VMB. B)
Gene expression fold changes in the STR.
doi:10.1371/journal.pone.0036191.g002
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subsequent ubiquitination and degradation of NRF2 [50].
Therefore, the down-regulation of both Keap1 and Dj-1 in our
study may be responsible for the failure of an up-regulation of the
Nrf2 target cytoprotective genes. The expression of several human
PD genes was down-regulated in our study including Uch-l1, Pink1,
Atp13a2, Omi/Htra2, Pla2g6 in VMB and STR in all the three
pesticide models. Several of these genes are involved in
mitochondrial dynamics and turnover [51], as well as ubiquitina-
tion of aberrantly misfolded proteins.
The ubiquitin proteosome system (UPS) plays a critical role in
PD pathogenesis. Three PD-related proteins PARKIN, PINK1
and DJ-1 physically interact and form a functional novel E3 ligase
complex called PPD to regulate UPS mediated protein degrada-
tion [52]. Evidence for UPS involvement in response to pesticide
exposure comes from the up-regulated genes in our study, Atxn1
and Sacs, and down-regulated heat shock protein 70 (Hsp70) gene.
SACSIN, the protein product of the Sacs gene, one of the top
ranking genes in our study, is a coregulator of chaperones and
prevents polyglutamine mediated aggregation of Atxn1 [53]. The
role of Atxn1 is unknown in PD, whereas SACSIN has been
classified as a molecular chaperone which cooperates with
members of the HSP70 chaperone [54]. There was a down-
regulation of heat shock protein 70 transcripts Hspa1a and Hspa1b
in our study. Wild type and mutant a-synuclein are degraded by
chaperone mediated autophagy (CMA) [55]. HSP70 keeps a-
synuclein soluble and promotes a-synuclein degradation via CMA
and/or the UPS, preventing toxicity [56]. We previously showed
that induction of HSP70 with celastrol produces protective effects
in the MPTP model of PD [57].
When comparing the same brain region between the PQ, PY
and MNPQ models, we found several concordant signaling
pathways which concur with human PD pathways identified in
independent gene expression profiling studies [18]. The Wnt
signaling pathway was a top concordant pathway in our study in
the VMB and STR. Wnt signaling is critically involved in key
processes for the formation and plasticity of the nervous system,
neurogenesis, axon guidance, dendritic development, synaptic
differentiation and plasticity [38]. Several WNTs are expressed in
the VMB where they regulate the birth of DA neurons [58] and
play an important role in dopamine related adult brain functions
[59]. Abnormalities of Wnt signaling are implicated in AD [38],
Figure 3. Common genes in the VMB between PQ, PY and MNPQ mouse models of PD. A) Venn diagram of 500 up-regulated VMB
transcripts from PQ, PY and MNPQ models of PD. B) Venn diagram of 500 down-regulated VMB transcripts from PQ, PY and MNPQ models of PD. C)
Common up-regulated genes in the VMB of PQ, PY and MNPQ models of PD. D) Common down-regulated genes in the VMB of PQ, PY and MNPQ
models of PD.
doi:10.1371/journal.pone.0036191.g003
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[63]. In our study, we observed a down-regulation of the Wnt gene
expression in VMB and STR including Wnt1, Wnt2, Wnt3, Wnt4,
Wnt5a, Wnt6, Wnt7a, Wnt7b, Wnt10a and Wnt10. Therefore, up-
regulation of Wnt gene expression may be an effective therapeutic
strategy for PD. A previous study found that Wnt5a-treated neural
stem cells are an efficient and safe source of DA neurons for cell
replacement therapy in PD, due to improved differentiation and
functional integration of stem cell–derived DA neurons in vivo [60].
Since we observed that Wnt5a signaling was impaired in pesticide
treated mice, this may contribute to impaired recovery of
dopaminergic neurons.
Embryonic stem cell pluripotency signaling was concordant in
the VMB and STR between the three pesticides induced PD
mouse models in our study. Wnt signaling maintains pluripotency
in embryonic stem cells [38]. Axonal guidance signaling which was
concordant in the VMB in our study is in agreement with human
PD studies [37] as well as in human neuroblastoma cell line
treated with PQ [64]. During development, precise temporal and
spatial gradients are responsible for guiding axons to their
appropriate targets. WNTs are morphogens that have been
identified as axon guidance molecules. The canonical pathway -
role of macrophages, fibroblasts and endothelial cells in rheuma-
toid arthritis (RA) suggests a relationship between chronic
inflammation and PD. Basal cell carcinoma signaling is one of
the pathways in our study, although its relationship to PD is not
yet known. The possible link between PD and basal cell carcinoma
cannot be ruled out in light of the finding that several PD genes
such as Parkin, Pink1 and Dj-1 have been associated with certain
cancers [65].
In conclusion, PQ, PY and MNPQ elicit concordant signaling
pathways in the VMB and STR in mouse models which overlap
with some pathways observed in human PD, suggesting that
similar mechanisms may occur in both. Common focus molecules
in the VMB and STR identified by network analysis and pathway
analysis may be used to identify targets for therapeutic
intervention.
Figure 4. Common genes in the STR between PQ, PY and MNPQ mouse models of PD. A) Venn diagram of 500 up-regulated STR
transcripts from PQ, PY and MNPQ models of PD. B) Venn diagram of 500 down-regulated STR transcripts from PQ, PY and MNPQ models of PD. C)
Common up-regulated genes in the STR of PQ, PY and MNPQ models of PD. D) Common down-regulated genes in the STR of PQ, PY and MNPQ
models of PD.
doi:10.1371/journal.pone.0036191.g004
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Ethics Statement
All experiments were conducted within National Institutes of
Health guidelines for animal research and were approved by the
Weill Cornell Medical College Animal Care and Use Committee
under animal protocol number 2010-0043. The mice were kept on
a 12-hr light/dark cycle, with food and water available ad libitum.
All surgeries were performed under isoflurane anesthesia and all
efforts were made to minimize animal suffering
Mice and pesticide paradigm
Three month old C57Bl6 male mice (Jackson Labs, Bar Harbor,
Maine, USA) were administered PQ, PY and MNPQ of pestanal
grade (Sigma Inc, MO, USA) using subcutaneous alzet pumps
(Durect Corporation, Cupertino, CA, USA) for 7 days. Concen-
trations were PQ (10 mg/kg/day), PY (3.5 mg/kg/day) and a
combination of PQ (10 mg/kg/day)+MN (30 mg/kg/day). Con-
trol C57Bl6 mice were administered PBS mixed with 1:8 mix of
ethanol (Sigma-Aldrich, St Louis, MO, USA) and neobeeH M-5 oil
(Stepan Company, Northfield, IL, USA) as vehicle. Six mice were
treated per group. PQ was dissolved in 16 phosphate buffered
saline (Mediatech Inc., Manassas, VA, USA) and PY and MN
were dissolved in a 1:8 mix of ethanol and neobeeH M-5 oil. The
vehicle for administration of all pesticides was PBS mixed with a
1:8 (ethanol: neobee oil) mixture. Mice were sacrificed at day 7
and their brains were harvested for immunohistochemistry and
RNA-Sequencing.
Immunohistochemistry
Free-floating brain sections were prepared and processed for
immunohistochemistry using a modified avidin-biotin-peroxidase
technique. Briefly, the sections were pretreated with 3% H2O2 in
0.1 M sodium phosphate-buffered saline (PBS) for 30 min. The
sections were rinsed in PBS twice for 5 min each. The sections
were incubated sequentially in (a) 1% bovine serum albumin
(BSA)/0.2% Triton X-100 (Sigma, St. Louis, MO) for 30 minutes,
(b) primary antibody (diluted in PBS/0.5% BSA) for 18 hours, (c)
appropriate biotinylated IgG (1:200, diluted in PBS/0.5% BSA,
Figure 5. Venn diagram of top ten signaling pathways in PQ, PY and MNPQ models of PD. A) Signaling pathways in VMB. B) Signaling
pathways in STR. C) Common overlapping pathways in VMB and STR are underlined. Considering the top ten canonical pathways there are six
pathways common in VMB of PQ, PY and MNPQ mouse models. There are three pathways common in STR of PQ, PY and MNPQ mouse models. All
the three common canonical pathways in STR overlap with pathways common in the VMB between the three pesticide models.
doi:10.1371/journal.pone.0036191.g005
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MNPQ mouse models of PD.
IPA Pathway Category Ventral mid brain (VMB) pathways common with human
SN [17] BA9 [17] PU [17] SFG [14] L SN [14] M SN [14] SN [37] OC[15] PU [15]
Amyotrophic Lateral Sclerosis Signaling xx
Glutamate Receptor Signaling xx
Calcium Signaling x xx
Actin Cytoskeleton Signaling xx x
PTEN Signaling xx x x
LXR/RXR Activation x
PPAR Signaling xx x x
PPARa/RXRa Activation x
ERK/MAPK Signaling xx x
Axonal Guidance Signaling xx x x
IL-6 Signaling xx
Ephrin Receptor Signaling x xxx
Erythropoietin Signaling x
G-Protein Coupled Receptor Signaling xx xx
RAR Activation xx x
IGF-1 Signaling x xxx x x
JAK/Stat Signaling x xxx x
Death Receptor Signaling x
Aryl Hydrocarbon Receptor Signaling xx
PI3K/AKT Signaling xx x x
Hepatic Cholestasis x
IL-10 Signaling x
All human IPA analysis were performed by [18].
x=Common Pathways.
SN: Substantia nigra, BA9: Brodman area 9, SFG: Superior frontal gyrus, L SN: Lateral substantia nigra, M SN: Medial substantia nigra, PU: Putamen, OC: Occipital cortex.
doi:10.1371/journal.pone.0036191.t002
Table 3. Overlapping signaling pathways between human PD transcriptome studies and signaling pathways in STR of PQ, PY and
MNPQ mouse models of PD.
IPA Pathway category Striatum (STR) pathways common with human
SN [17] BA9 [17] PU [17] SFG [14] L SN [14] M SN [14]SN [37] OC [15] PU [15]
Calcium Signaling xx x
PTEN Signaling x xxxx
Amyotrophic Lateral Sclerosis Signaling xx
Axonal Guidance Signaling xx x x
IL-6 Signaling xx
G-Protein Coupled Receptor Signaling xx xx
Hepatic Cholestasis x
PPARa/RXRa Activation x
Cardiac b-adrenergic Signaling xx
Estrogen Receptor Signaling xxx
Wnt/b-catenin Signaling x
Serotonin Receptor Signaling x
LXR/RXR Activation x
All human IPA analysis were performed by [18].
x=Common Pathways.
SN: Substantia nigra, BA9: Brodman area 9, SFG: Superior frontal gyrus, L SN: Lateral substantia nigra, M SN: Medial substantia nigra, PU: Putamen, OC: Occipital cortex.
doi:10.1371/journal.pone.0036191.t003
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biotin-peroxidase complex (1:200 in PBS; Vector Laboratories) for
1 hour. The immunoreactions were visualized using 3,39-diami-
nobenzidine tetrahydrochloride dihydrate (DAB) as the chromo-
gen. All incubations and rinses were performed at room
temperature with agitation using an orbital shaker. The sections
were mounted onto gelatin-coated slides, dehydrated, cleared in
xylene and coverslipped. The primary antibodies used were rabbit
anti-tyrosine hydroxylase (TH) affinity purified antibody (1:4,000;
Chemicon, Temecula, CA, USA) and mouse anti-a-synuclein
(1:1,000, BD Transduction, Chicago, IL, USA). The total
numbers of TH positive neurons were counted using a
stereological technique (optical fractionator) from the Stereo
Investigator software v. 9.12 (Microbrightfield, Burlington, VT).
A series of seven cryosections (50-mm thick) through the SN per
mouse was analyzed. For quantitation of a-synuclein immunore-
active cells in the SN, sections adjacent to those used for counting
TH were used and counted manually. Seven sections encompass-
ing the entire SN and containing the SN were analyzed.
Library preparation and RNA-Sequencing
RNA-Sequencing was carried out for three replicates per
pesticide per brain region. The right half of the mouse brain was
used for dissecting out the VMB and STR for RNA isolation using
Trizol Reagent (Invitrogen, Carlsbad, California,USA). RNA was
purified using RNA clean and concentrator (Zymo Research
Corporation, Irvine, CA, USA). RNA was quantified using the
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA,
USA). One microgram of total RNA with a RNA Integrity
Number (RIN) more than eight was used for library preparation
using mRNA-Seq sample preparation kit (Illumina, Inc., San
Diego, CA, USA). RNA-Sequencing was done using an Illumina
Genome Analyzer.
Analysis of RNA-Seq data
After mRNA library quality check using the Bioanalyzer,
polyadenylated transcriptome sequencing was performed follow-
ing the Illumina protocol using the GAIIx sequencer with 40
cycles of incorporation in single end mode. 20–30 M short reads
were obtained for each experiment and were aligned to RefSeq
Figure 6. Global gene network in VMB of PQ, PY and MNPQ mouse models of PD. The genes from the most significant network of each
individual pesticide mouse model were overlayed to generate global gene networks in the VMB. Down-regulated genes are highlighted in green, up-
regulated genes are highlighted in red. The focus molecules-G protein coupled receptors (GPCRs) members, Kelch-like ECH-associated protein 1
(Keap1) and peroxisome proliferator-activated receptor delta (Ppard) are down-regulated in VMB.
doi:10.1371/journal.pone.0036191.g006
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[66]. All RNA-Seq had .70% mappable reads. After alignment,
transcript levels were then estimated and normalized using the
RPKM approach [67]. Differential expression was analyzed using
unpaired t-tests and the Benjamini-Hochberg correction was
applied to control the false discovery rate. All statistical analysis
was performed using the R statistical software. The data discussed
in this publication has been deposited in NCBI’s Gene Expression
Omnibus and are accessible through GEO Series accession
number GSE36232 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE36232).
Quantitative real time PCR
Gene expression for seven PD related genes were further
validated using quantitative reverse transcriptase real time (RT)
PCR. cDNA was prepared from 500 ng of total RNA with the
same RNA samples used for RNA-Sequencing experiments using
superscript III first strand synthesis system for RT-PCR (Invitro-
gen, Carlsbad, California, USA). Quantitative RT-PCR was
performed using Taqman gene expression master mix and
Taqman primer probe mix in a 8 mL reaction mix in 7900 HT
Fast Real time PCR system (Applied Biosystems, Carlsbad,
California, USA) using Taqman assays (Table 1). The house
keeping gene was 18S ribosomal RNA. Fold changes were
calculated using the 2
2DDCt method and plotted as fold differences
of relative gene expression normalized to controls.
Pathway Analysis
All gene sets were subject to ingenuity pathway analysis (IPA,
Ingenuity Systems, www.ingenuity.com) in order to identify
significantly deregulated canonical pathways and to generate
networks of deregulated genes. To do this, the gene expression
data sets were uploaded into the application. All genes with $1.5
or #1.5 gene expression fold changes were selected for uploading.
Each gene identifier was mapped to its corresponding gene object
in the Ingenuity Pathways knowledge base. On the basis of the IPA
library, canonical pathway analyses identified pathways that were
most significant in the data sets. To generate networks, the genes
from the data set were overlaid onto a global molecular network
developed from information contained in the Knowledge Base.
Gene networks were then algorithmically generated on the basis of
their connectivity. The significance of the association between the
datasets and the canonical pathways were measured using the
Fischer’s exact test, to calculate the probability that the association
between the gene list and the canonical pathway was explained by
chance alone and calculating the ratio of the number of genes
from the gene list that mapped to the pathway divided by the total
number of molecules that exist in the canonical pathway.
Pathways with a high ratio and a low P-value are indicative of
Figure 7. Global gene network in STR of PQ, PY and MNPQ mouse models of PD. The genes from the most significant network of each
individual pesticide mouse model were overlayed to generate global gene networks in the STR. Down-regulated genes are highlighted in green, up-
regulated genes are highlighted in red. The focus molecules- G protein coupled receptors (GPCRs) members and Ppard are down-regulated while
Atxn1 is up-regulated.
doi:10.1371/journal.pone.0036191.g007
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represented as 2log(p value) and all values above 1.3 are
significant.
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